Consolidated figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67 | 70 | 71 | 75 | 82 | 85 | 69 | 89 | 94 | 82 | 103 | 96 | |
| COGS | 35 | 36 | 37 | 42 | 43 | 43 | 33 | 48 | 47 | 38 | 56 | 49 |
| Gross profit | 33 | 34 | 34 | 33 | 39 | 43 | 37 | 41 | 47 | 44 | 47 | 47 |
| 23 | 25 | 25 | 24 | 27 | 29 | 31 | 30 | 35 | 34 | 35 | 36 | |
| 10 | 9 | 9 | 9 | 12 | 13 | 6 | 11 | 12 | 10 | 12 | 11 | |
| OPM % | 14.4% | 12.6% | 13% | 12.6% | 14.3% | 15.6% | 8.3% | 12.3% | 12.8% | 12.6% | 12.1% | 11.6% |
| Depreciation | 3 | 3 | 3 | 4 | 5 | 5 | 3 | 5 | 5 | 5 | 4 | 4 |
| Interest | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 2 |
| 1 | 2 | 1 | 1 | 0 | 2 | 6 | 1 | 0 | 1 | 2 | 1 | |
| Profit before tax | 5 | 6 | 5 | 5 | 5 | 8 | 6 | 4 | 5 | 4 | 8 | 6 |
| Tax | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
| Tax % | 45.1% | 24.8% | 9.1% | 16.1% | 11.6% | 11.3% | 13.2% | 32.1% | 21.4% | 11.1% | 7.1% | 20.5% |
| 3 | 4 | 5 | 4 | 4 | 7 | 5 | 3 | 4 | 4 | 7 | 5 | |
| PAT margin % | 4% | 6.2% | 6.5% | 5.2% | 5.4% | 8.1% | 7.5% | 3.2% | 4.6% | 4.5% | 7% | 4.7% |
| EPS (₹) | 1.3 | 2 | 2.3 | 2.3 | 2.6 | 3.4 | 2.6 | 1 | 1.9 | 1.7 | 2.9 | 2.2 |
| Results filing | — | — | — | — | — | — | — | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | Results filing for Jun 2026 |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | +19% | +22.4% | +13.2% | +15.8% | +23% | +21.5% | -2.6% | +19.7% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed |
|---|---|---|---|---|---|
| Pharma Formulations | 47.9 | 3.4 | 360.53 | 43.96 | 316.57 |
| Agrochemicals | 43.83 | 6.31 | 312.73 | 58.41 | 254.32 |
| +13.8% |
| -3.8% |
| +48.2% |
| +7.9% |
| PAT YoY % | -65.3% | -34.8% | -35% | -40.3% | +67.2% | +59.9% | +12.8% | -27.1% | -2.9% | -47.1% | +38.2% | +59.6% |
| Unallocated other operating revenue | 2.44 | 0 | 0 | 0 | — |
| Active Pharma Ingredient (API) | 2.18 | -1.98 | 125.57 | 14.48 | 111.09 |
₹ crore by quarter